PPD Development, L.P.
Records under this name other than the patents PPD Development, L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,233,182 | Substituted Spirocyclic Inhibitors of Autotaxin Formerly held Lapsed on the fee record Ended Mar 19, 2023 · High confidence | Lapsed on the fee record | Ended Mar 19, 2023 | High confidence |
| US 10,011,601 | Substituted Spirocyclic Inhibitors of Autotaxin Formerly held Lapsed on the fee record Ended Jul 3, 2022 · High confidence | Lapsed on the fee record | Ended Jul 3, 2022 | High confidence |
| US 6,507,829 | Textual data classification method and apparatus Lapsed on the fee record Ended Jan 14, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2015 | From the USPTO record |
| US 6,767,905 | Use of angiotensin II receptor antagonists for treating acute myocardial infarction Lapsed on the fee record Ended Jul 27, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 27, 2012 | From the USPTO record |
| US 6,071,743 | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes Lapsed on the fee record Ended Jun 6, 2008 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2008 | From the USPTO record |
| US 6,613,506 | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes Lapsed on the fee record Ended Sep 2, 2007 · From the USPTO record | Lapsed on the fee record | Ended Sep 2, 2007 | From the USPTO record |
| US 6,537,972 | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes Lapsed on the fee record Ended Mar 25, 2007 · From the USPTO record | Lapsed on the fee record | Ended Mar 25, 2007 | From the USPTO record |
| US 6,436,634 | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes Lapsed on the fee record Ended Aug 20, 2006 · From the USPTO record | Lapsed on the fee record | Ended Aug 20, 2006 | From the USPTO record |
| US 6,426,412 | Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements Lapsed on the fee record Ended Jul 30, 2006 · From the USPTO record | Lapsed on the fee record | Ended Jul 30, 2006 | From the USPTO record |
| US 6,326,152 | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes Lapsed on the fee record Ended Dec 4, 2005 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2005 | From the USPTO record |